1Department of Pediatric Urology, University Hospital of Nijmegen, The Netherlands.
Multicentre trials improved survival for pediatric rhabdomyosarcoma, particularly paratesticular rhabdomyosarcoma (PTRM). Research now focuses on refining treatments to minimize severe side effects and reduce therapy risks.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: